Nishiyama Y - Search Results

1

Paclitaxel-2'-Ethylcarbonate prodrug can circumvent P-glycoprotein-mediated cellular efflux to increase drug cytotoxicity.

Tanino T, Nawa A, Kondo E, Kikkawa F, Daikoku T, Tsurumi T, Luo C, Nishiyama Y, Takayanagi Y, Nishimori K, Ichida S, Wada T, Miki Y, Iwaki M. Tanino T, et al. Among authors: nishiyama y. Pharm Res. 2007 Mar;24(3):555-65. doi: 10.1007/s11095-006-9171-6. Pharm Res. 2007. PMID: 17245652

2

Gene directed enzyme prodrug therapy for ovarian cancer: could GDEPT become a promising treatment against ovarian cancer?

Nawa A, Tanino T, Luo C, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Nishiyama Y, Kikkawa F. Nawa A, et al. Among authors: nishiyama y. Anticancer Agents Med Chem. 2008 Feb;8(2):232-9. doi: 10.2174/187152008783497000. Anticancer Agents Med Chem. 2008. PMID: 18288924 Review.

3

Enhanced cytotoxicity with a novel system combining the paclitaxel-2'-ethylcarbonate prodrug and an HSV amplicon with an attenuated replication-competent virus, HF10 as a helper virus.

Ishida D, Nawa A, Tanino T, Goshima F, Luo CH, Iwaki M, Kajiyama H, Shibata K, Yamamoto E, Ino K, Tsurumi T, Nishiyama Y, Kikkawa F. Ishida D, et al. Among authors: nishiyama y. Cancer Lett. 2010 Feb 1;288(1):17-27. doi: 10.1016/j.canlet.2009.06.014. Epub 2009 Jul 14. Cancer Lett. 2010. PMID: 19604626

Virol. 148 (2003) 813-825; S. Kohno, C. Lou, F. Goshima, Y. Nishiyama, T. Sata, Y. Ono, Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer, Urology 66 (2005) 1116-1121; D. Watanabe, F. Goshima, I. Mori, Y. Tamada, Y …

Virol. 148 (2003) 813-825; S. Kohno, C. Lou, F. Goshima, Y. Nishiyama, T. Sata, Y. Ono, Herpes simplex virus type 1 mut …

4

Intercellular trafficking and cytotoxicity of recombinant HSV-1 thymidine kinase fused with HSV-2 US11 RXP repeat peptide.

Luo C, Nawa A, Yamauchi Y, Kohno S, Ushijima Y, Goshima F, Kikkawa F, Nishiyama Y. Luo C, et al. Among authors: nishiyama y. Virus Genes. 2007 Jun;34(3):263-72. doi: 10.1007/s11262-006-0013-8. Epub 2006 Aug 22. Virus Genes. 2007. PMID: 16927131

5

Replication-competent, oncolytic herpes simplex virus type 1 mutants induce a bystander effect following ganciclovir treatment.

Luo C, Mori I, Goshima F, Ushijima Y, Nawa A, Kimura H, Nishiyama Y. Luo C, et al. Among authors: nishiyama y. J Gene Med. 2007 Oct;9(10):875-83. doi: 10.1002/jgm.1085. J Gene Med. 2007. PMID: 17685493

6

Oncolytic viral therapy for human ovarian cancer using a novel replication-competent herpes simplex virus type I mutant in a mouse model.

Nawa A, Nozawa N, Goshima F, Nagasaka T, Kikkawa F, Niwa Y, Nakanishi T, Kuzuya K, Nishiyama Y. Nawa A, et al. Among authors: nishiyama y. Gynecol Oncol. 2003 Oct;91(1):81-8. doi: 10.1016/s0090-8258(03)00417-7. Gynecol Oncol. 2003. PMID: 14529666

7

Herpes simplex virus UL14 protein blocks apoptosis.

Yamauchi Y, Daikoku T, Goshima F, Nishiyama Y. Yamauchi Y, et al. Among authors: nishiyama y. Microbiol Immunol. 2003;47(9):685-9. doi: 10.1111/j.1348-0421.2003.tb03432.x. Microbiol Immunol. 2003. PMID: 14584616 Free article.

8

Inhibition of S-phase cyclin-dependent kinase activity blocks expression of Epstein-Barr virus immediate-early and early genes, preventing viral lytic replication.

Kudoh A, Daikoku T, Sugaya Y, Isomura H, Fujita M, Kiyono T, Nishiyama Y, Tsurumi T. Kudoh A, et al. Among authors: nishiyama y. J Virol. 2004 Jan;78(1):104-15. doi: 10.1128/jvi.78.1.104-115.2004. J Virol. 2004. PMID: 14671092 Free PMC article.

Kudoh, M. Fujita, T. Kiyono, K. Kuzushima, Y. Sugaya, S. Izuta, Y. Nishiyama, and T. Tsurumi, J. Virol. 77:851-861, 2003). Thus, the EBV lytic program appears to promote specific cell cycle-associated activity involved in the progression from G1 to S phase. . …

Kudoh, M. Fujita, T. Kiyono, K. Kuzushima, Y. Sugaya, S. Izuta, Y. Nishiyama, and T. Tsurumi, J. Virol. 77:851-861, 200 …

9

Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.

Zhang L, Daikoku T, Ohtake K, Ohtsuka J, Nawa A, Kudoh A, Iwahori S, Isomura H, Nishiyama Y, Tsurumi T. Zhang L, et al. Among authors: nishiyama y. J Virol Methods. 2006 Nov;137(2):177-83. doi: 10.1016/j.jviromet.2006.06.017. Epub 2006 Jul 18. J Virol Methods. 2006. PMID: 16854473

10

Microarray analysis of transcriptional responses to infection by herpes simplex virus types 1 and 2 and their US3-deficient mutants.

Kamakura M, Nawa A, Ushijima Y, Goshima F, Kawaguchi Y, Kikkawa F, Nishiyama Y. Kamakura M, et al. Among authors: nishiyama y. Microbes Infect. 2008 Apr;10(4):405-13. doi: 10.1016/j.micinf.2007.12.019. Epub 2008 Jan 9. Microbes Infect. 2008. PMID: 18403238 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,809 results

Search Page

Filters